Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) Other Non Operating Income (2023 - 2025)

Metagenomi (MGX) has disclosed Other Non Operating Income for 3 consecutive years, with -$11000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Non Operating Income rose 77.55% to -$11000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$91000.0, a 56.04% increase, with the full-year FY2025 number at -$91000.0, up 56.04% from a year prior.
  • Other Non Operating Income was -$11000.0 for Q4 2025 at Metagenomi, down from -$2000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $16000.0 in Q2 2023 to a low of -$85000.0 in Q3 2023.
  • A 3-year average of -$31000.0 and a median of -$30000.0 in 2024 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: crashed 4900.0% in 2024, then surged 96.49% in 2025.
  • Metagenomi's Other Non Operating Income stood at -$4000.0 in 2023, then plummeted by 1125.0% to -$49000.0 in 2024, then soared by 77.55% to -$11000.0 in 2025.
  • Per Business Quant, the three most recent readings for MGX's Other Non Operating Income are -$11000.0 (Q4 2025), -$2000.0 (Q3 2025), and -$70000.0 (Q2 2025).